Analysts think GILD stock price could increase by 0%
Apr 01, 2025, 11:25 AM
-4.92%
What does GILD do
Gilead Sciences, headquartered in Foster City, California, employs 18,000 people and focuses on developing medicines for HIV, hepatitis, COVID-19, and cancer. Its portfolio includes numerous marketed products and several promising candidates.
29 analysts think GILD stock price will increase by 0.13%. The current median analyst target is $112.20 compared to a current stock price of $112.05. The lowest analysts target is $82.82 and the highest analyst target is $147.00.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
